Type 2 Diabetes

If you could intensify therapy for your type 2 diabetes patients without risking hypoglycemia and/or additional weight gain, the regimen might look like this.

When you weigh the potential benefits to the patient against the risk of treatment-related adverse effects and drug-drug interactions, most diabetic patients will benefit from treatment with statins.

A 64-year-old obese man with type 2 diabetes presents with abrupt onset of extremely itchy rash on both upper, inner thighs. He notes mild to moderate clear oozing and a foul odor. What is this?

Researchers in Wisconsin recently announced the discovery of a gene which could help explain certain traits seen in patients diagnosed with diabetes.

Some researchers now suspect that type 2 diabetes may itself be an independent risk factor for osteoarthritis and have proposed a "diabetes-induced phenotype."

In this issue of Cardiology Review, we cover a wide variety of topics while saying goodbye to the summer of 2014.

The 74th Scientific Sessions of the American Diabetes Association (ADA) brought together more than 17,300 attendees from more than 121 countries. This year's program included 96 symposia, 50 oral abstract sessions, 10 interest group discussions, 18 meet-the-expert sessions, and 10 special lectures and addresses. Cardiology Review is covering 6 of the top sessions.

The incidence of type 2 diabetes mellitus tripled in the last 20 years. What has that meant for rates of complications?

Which of the following statements about diabetic cheiroarthropathy are true?

Trulicity (dulaglutide) is a once-weekly subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.

Patients diagnosed with type 1 diabetes have long known the benefits of ease and convenience that comes with using an insulin pump instead of relying on multiple daily insulin injections to control their condition. A recent study has shown that using a pump is also associated with positive effects on long-term cardiovascular risk and mortality.

Researchers at the Children's Hospital of Philadelphia recently released the results of a study that identified a protein that could play a key role in a variety of diseases.

Inpatient hyperglycemia found on admission blood tests can be explained by medications, stress reaction, or, “Other.” When is “other” a red flag for diabetes? A new online tool from Scotland may help answer that.

The results of a recently released study have once again shown the impact gut microbes can have on the health of patients with diabetes.

Adherence is defined as conforming to the recommendations made by the provider with respect to timing, dosage, and frequency of medication taking, and following these recommendations is important for patients with multiple sclerosis (MS) to fully benefit from disease-modifying therapies (DMTs).

Researchers have identified several combinations of drugs that outperform metformin monotherapy in patients with type 2 diabetes mellitus.

Using an experimental and highly sensitive test for cardiac troponin, a team of Johns Hopkins researchers found undetected signs of heart muscle damage in people with diabetes and pre-diabetes. That may suggest that hypoglycemia directly damages the heart.

Medication commonly used to reduce cholesterol could also be used to help patients with diabetes reduce their risk of serious complications like blindness and amputations.

Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) is a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity.

The makeup of a person's brain chemistry could play a role in their environmental food cues, according to the results of a new study.

"When I went to school, all we had was insulin and sulfonylureas...metformin was a big deal when it came out." With new drugs approved every year now, how do you decide when to try them?

Truths about necrobiosis lipoidica, advantages of SGLT2 inhibitors, rash in an obese teen, benefits of insulin therapy, knee effusions with diabetes and hypertension-these questions about diabetes put your knowledge to the test.

Drug formerly known as Zerenex gets approval following Phase 3 clinical trials

Not all patients who meet indications for statin therapy are at equal risk for the development of diabetes. What would you tell this 58-year-old man who just learned he’s a candidate for a high-potency formulation?

Is this 58-year-old man going to be at risk?

Hypertension has long been linked to obesity, but a new study shows that where that fat is matters. A team of researchers at University of Texas Southwestern Medical Center in Dallas, TX conclude that when that fat is in the viscera-as opposed to accumulating under the skin-there is a strong chance patients will develop hypertension.

Patients diagnosed with type 1 diabetes are at higher risk for developing major health complications but up until now there had been no reliable way to determine which complications a patient might develop or how severe they might be.

Lowering blood pressure is vital to care and should remain a priority in preventing and managing cardiovascular and microvascular complications.

A 3-year study of a product meant to help patients dealing with a wide range of conditions including diabetes, hypertension, and weight loss showed positive results according to manufacturer EnteroMedics, Inc.

Gastroparesis, or delayed gastric emptying, remains misunderstood despite rising prevalence, according to a news release from the International Foundation for Functional Gastrointestinal Disorders (IFFGD), a nonprofit research and education organization addressing issues surrounding gastrointestinal and motility disorders.